In the TMC cohort 43% of patients exhibited ‘low’ P2Y13 mRNA expression, which was ranked among the top 4% underexpressed genes in Chen_Liver dataset, and included HCC samples of viral and non-viral origin. This evidence concerns the gene P2RY13 and hepatocellular carcinoma.